Evidence map›Paper›PMID 34617619›Full record

ArticleJournal of labelled compounds & radiopharmaceuticals2022

Exploration of alcohol-enhanced Cu-mediated radiofluorination toward practical labeling.

Dong Zhou, Wenhua Chu, John A Katzenellenbogen

Abstract read
In one paragraph

Article in Journal of labelled compounds & radiopharmaceuticals, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Chemical science · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. [Scientific reports · 2023
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Dong ZhouDepartment of Radiology, School of Medicine, Washington University in Saint Louis, Saint Louis, Missouri, USA.ORCID 0000-0002-6707-4878
Wenhua ChuDepartment of Radiology, School of Medicine, Washington University in Saint Louis, Saint Louis, Missouri, USA.
John A KatzenellenbogenDepartment of Chemistry and Cancer Center at Illinois, University of Illinois at Urbana-Champaign, Champaign, Illinois, USA.

Funding

RATIONAL DESIGN OF BREAST TUMOR IMAGING AGENTSR01CA025836 · NCI · UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN · PI KATZENELLENBOGEN, JOHN A. · 1985 to 2017
$4.2M
Imaging and Targeted Auger Radiotherapy of High-Grade GliomaR01EB029752 · NIBIB · WASHINGTON UNIVERSITY · PI GARBOW, JOEL RICHARD, ROGERS, BUCK E. · 2020 to 2023
$3.1M
Chemical, structural and molecular rules for fully antagonizing the estrogen receptorR01CA220284 · NCI · UNIVERSITY OF FLORIDA · PI KATZENELLENBOGEN, BENITA S, KATZENELLENBOGEN, JOHN A. · 2018 to 2022
$2.8M
RADIOPHARMACEUTICALS FOR BREAST TUMOR IMAGING &THERAPYR37CA025836 · NCI · UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN · PI KATZENELLENBOGEN, JOHN A. · 1999 to 2006
$2.6M
NCI NIH HHS R01 CA025836NCI NIH HHS R01 CA220284NCI NIH HHS R37 CA025836NIBIB NIH HHS R01 EB029752
6 · The paper itself

Abstract

Copper-mediated nucleophilic radiofluorination using boronic precursors is a promising, general method to label aromatic compounds with [

Indexed as

Fluorine RadioisotopesRadiopharmaceuticalsCopperFluoridesIsotope LabelingRadiochemistryCopperFluoridesFluorine RadioisotopesRadiopharmaceuticalscopper-mediated radiosynthesisfluorine-18optimizationradiofluorination

Identifiers

PMID34617619
PMCPMC8727449

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.